Jonathan Yeow

This paper develops an injectable hydrogel platform with poly(orthoester) microparticles for long-term, zero-order drug release, demonstrating in vitro and in vivo efficacy for up to 12 months.

This study shows that the maturity of the endothelial glycocalyx affects how charged nanoparticles and polymers interact with endothelial cells, influencing toxicity and binding.

This paper develops a 3D printing method to create tunable drug delivery systems that control vaccine-induced antibody responses.